SBN-284
Product Specifications
Target
NOD-like Receptor (NLR), Cholinesterase (ChE)
Related Pathways
Immunology/Inflammation, Neuroscience
Bioactivity
SBN-284 (compound 3x) acts as a dual inhibitor of cholinesterases (Cholinesterases) and NLRP3 inflammasomes, demonstrating blood-brain barrier permeability. It exhibits IC50 values of 0.37, 0.31, and 0.29 μM against EeAChE, hAChE, and eqBChE respectively, and an EC50 value of 1 μM against NLRP3. SBN-284 is utilized in Alzheimers disease research.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS2557916-01 0.025 mg
Armenian Hamster IgG Isotype Control (APC/Cy5.5 Conjugated)
Sign In for Pricing
View Details MBS2557916-02 0.05 mg
Armenian Hamster IgG Isotype Control (APC/Cy5.5 Conjugated)
Sign In for Pricing
View Details MBS2557916-03 0.1 mg
Armenian Hamster IgG Isotype Control (APC/Cy5.5 Conjugated)
Sign In for Pricing
View Details MBS2557916-04 0.2 mg
Armenian Hamster IgG Isotype Control (APC/Cy5.5 Conjugated)
Sign In for Pricing
View Details MBS2557916-05 5x 0.2 mg
Armenian Hamster IgG Isotype Control (APC/Cy5.5 Conjugated)
Sign In for Pricing
View Details orb3125780 100 µL
Firefly Luciferase Mouse mAb, Pacific Blue conjugated
Sign In for Pricing
View Details